BRCA1 testing by Górski, Bohdan & Lubiński, Jan
H He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2008; 6(2) 81
Hereditary Cancer in Clinical Practice 2008; 6(2) pp. 81-82
BRCA1testing
Bohdan Górski, Jan Lubiñski
International Hereditary Cancer Centre, Department of Genetics and Pathology, Szczecin, Poland
Corresponding author: Bohdan Górski, International Hereditary Cancer Centre, Department of Genetics and Pathology,
Pomeranian Medical University, ul. Po³abska 4, 70-115 Szczecin, Poland, e-mail: gorskib@sci.pam.szczecin.pl
Mutations in BRCA1 confer a high lifetime risk for
both breast and ovarian cancer. Many different BRCA1
mutations have been described in families with early-
onset breast and ovarian cancer [1, 2]. The presence
of recurrent mutations in BRCA1 suggests the presence
of founder effects. BRCA1 “de novo” mutations are
very rare. 66 families were studied in Szczecin with
strong aggregations of breast/ovarian cancers.
Mutations were found in 35 (53%) of the 66 families.
Three BRCA1 abnormalities–5382insC, C61G, and
4153delA–accounted for 51, 20, and 11% of the
identified mutations, respectively [3]. Similar results were
reported in Gliwice, Gdañsk and Poznañ centres [4-6].
Additional evaluation of 200 families originating from
all regions of Poland (with at least 3 breast/ovarian
cancers) revealed that constitutional BRCA1 mutations
can be detected in 64% (128/200) of these families,
and 90% of all of them carried one of the 3 common
founder mutations (5382insC, C61G and 4153delA)
[7]. Genetic testing for these BRCA1 mutations is
inexpensive and relatively simple in Poland (~100 Euro
including genetic counselling). It is based on the
“multiplex PCR” method with almost 100% specificity
in detection of three common Polish BRCA1 mutations.
In 2006, 3500 unselected incident cases of early-onset
breast cancers were screened for presence of the three
common Polish BRCA1 mutations. The proportion of
cases with an identified mutation was 5.7% [8]. In 
a similar study of 500 unselected ovarian cancers,
common BRCA1 mutations were detected in 13% of
cases [9, 10]. It is possible to increase women’s
awareness about hereditary cancer through the popular
press. Genetic testing was offered to 5000 Polish
women through an announcement placed in a popular
women’s magazine „Twój Styl”. A total of 5024 women
who qualified received a free genetic test for three
mutations in BRCA1 which are common in Poland. Out
of these, 198 women (3.9%) were found to carry 
a BRCA1 mutation. Genetic testing for BRCA1 mutations
in Poland should be recommended for adult females
who:
• fulfil clinical criteria of hereditary breast/ovarian cancer,
• are affected with breast or ovarian cancer,
• are healthy but have at least one relative with
breast/ovarian cancer (breast cancer diagnosed
under age 50).
Genetic testing for presence of BRCA1 mutations
should be preceded and followed by genetic
counselling. So far nearly 4500 BRCA1 mutation
carriers have been detected at the International
Hereditary Cancer Centre in Szczecin (the world’s
largest registry of females diagnosed and under
surveillance by a single centre).
We believe that the “Polish model” of solving the
problem of BRCA1/BRCA2 testing can be valuable for
many populations with a relatively high level of genetic
homogeneity.
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